Apexigen, Inc. – NASDAQ:APGN

Financial Health
0
1
2
3
4
5
6
7
8
9

Apexigen stock price monthly change

-18.12%
month

Apexigen stock price quarterly change

-0.03%
quarter

Apexigen key metrics

Market Cap
9.57M
Enterprise value
N/A
P/E
-0.34
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-331.29
Revenue
N/A
EBITDA
-27.78M
Income
-26.65M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Apexigen stock price history

Apexigen stock forecast

Apexigen financial statements

Apexigen, Inc. (NASDAQ:APGN): Profit margin
Sep 2022 0 -8.18M
Dec 2022 0 -6.53M
Mar 2023 0 -5.89M
Jun 2023 0 -6.04M
Apexigen, Inc. (NASDAQ:APGN): Earnings per share (EPS)
2023-05-17 0.19 0.25
2023-08-10 -0.19 0.24
Apexigen, Inc. (NASDAQ:APGN): Debt to assets
Sep 2022 27574000 17.16M 62.24%
Dec 2022 22855000 16.47M 72.1%
Mar 2023 17576000 14.46M 82.29%
Jun 2023 13083000 15.40M 117.75%
Apexigen, Inc. (NASDAQ:APGN): Cash Flow
Sep 2022 387.79M -6.44B 6.19B
Dec 2022 -3.05M 6.02M -878K
Mar 2023 -6.76M 2.15M 2.54M
Jun 2023 -3.00M 0 -360K

Apexigen alternative data

Apexigen, Inc. (NASDAQ:APGN): Employee count
Aug 2023 12
Sep 2023 11
Oct 2023 11
Nov 2023 11
Dec 2023 11
Jan 2024 11
Feb 2024 11
Mar 2024 11
Apr 2024 11
May 2024 11
Jun 2024 11
Jul 2024 11

Apexigen other data

10.88% -4.57%
of APGN is owned by hedge funds
2.15M -1.01M
shares is hold by hedge funds
  • When is Apexigen's next earnings date?

    Unfortunately, Apexigen's (APGN) next earnings date is currently unknown.

  • Does Apexigen pay dividends?

    No, Apexigen does not pay dividends.

  • How much money does Apexigen make?

    Apexigen has a market capitalization of 9.57M. Apexigen made a loss 31.45M US dollars in net income (profit) last year or $0.24 on an earnings per share basis.

  • What is Apexigen's stock symbol?

    Apexigen, Inc. is traded on the NASDAQ under the ticker symbol "APGN".

  • What is Apexigen's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Apexigen?

    Shares of Apexigen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Apexigen have?

    As Jul 2024, Apexigen employs 11 workers.

  • When Apexigen went public?

    Apexigen, Inc. is publicly traded company for more then 4 years since IPO on 22 Feb 2021.

  • What is Apexigen's official website?

    The official website for Apexigen is apexigen.com.

  • Where are Apexigen's headquarters?

    Apexigen is headquartered at 75 Shoreway Road, San Carlos, CA.

  • How can i contact Apexigen?

    Apexigen's mailing address is 75 Shoreway Road, San Carlos, CA and company can be reached via phone at +65 09316236.

Apexigen company profile:

Apexigen, Inc.

apexigen.com
Exchange:

NASDAQ

Full time employees:

11

Industry:

Biotechnology

Sector:

Healthcare

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

75 Shoreway Road
San Carlos, CA 94070

CIK: 0001814140
:
: